Lian Zhang

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients.

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients.

Journal: Scientific reports

Published: May 13, 2022

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy Response.

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy Response.

Journal: Frontiers in molecular biosciences

Published: March 26, 2022

Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.

Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.

Journal: Disease markers

Published: December 01, 2021

IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma.

IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma.

Journal: Cell death & disease

Published: July 14, 2021

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor.

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor.

Journal: Frontiers in oncology

Published: June 07, 2021

The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors.

The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors.

Journal: Frontiers in pharmacology

Published: May 19, 2021

Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer.

Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer.

Journal: Frontiers in immunology

Published: December 30, 2020

Influence of UGT1A1 6/28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen.

Influence of UGT1A1 6/28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen.

Journal: Pharmacogenomics and personalized medicine

Published: December 22, 2020

ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.

ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.

Journal: Cell death & disease

Published: November 06, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026